About
Bradford
  HIV/AIDS
Articles
  Alternative
Therapies
  HIV/AIDS
Videos
  HIV/AIDS
Links
  HIV/AIDS
News

Introduction:
Positively Positive
- Living with HIV
  Out
About
HIV
  Resume/
Curriculum Vitae:
HIV / AIDS Involvements
  Biography   HIV/AIDS
News Archive
HIV/AIDS News Bradford McIntyre Positively Positive Living with HIV/AIDS
   
AIDS Awareness Red Ribbon


www.ecdc.europa.eu/en

Press Release
March 25, 2025

COVID-19 vaccination reduces risk of ‘long COVID’ in adults

Stockholm, 25/3/2025: COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).

The review focused on studies conducted in Europe and similar regions. Given the very wide range of definitions for ‘long COVID’, the review focussed on those studies that specifically applied the World Health Organization’s clinical case definition for post COVID-19 condition (PCC). It found seven high-quality studies in adults, of which six reported a statistically significant reduction in the risk of PCC for vaccinated adults compared to those who were not vaccinated. However, there is still limited evidence on whether vaccination reduces the duration of PCC symptoms, or the risk of developing PCC in children, adolescents, and immunocompromised individuals.
‘An important takeaway from this review is that vaccination not only protects against severe outcomes of acute illness during a pandemic but may also help reduce the risk of significant long-term effects,’ said Edoardo Colzani, ECDC Head of Respiratory Viruses and Legionella.

This research highlights the importance of COVID-19 vaccination, not only for preventing severe illness and hospitalisation but also for reducing the risk of prolonged symptoms after SARS-CoV-2 infection. Further research studies on the role of vaccination in reducing the risk and duration of PCC are still required. In particular, studies should focus on groups such as children, adults, and immunocompromised individuals. This will help provide more comprehensive insights to guide public health strategies.

This review follows an earlier review by ECDC that showed that the prevalence of PCC symptoms was higher among those who experienced more severe COVID-19 disease.


Contact:

European Centre for Disease Prevention and Control (ECDC)

Gustav III:s boulevard 40, 169 73 Solna, Sweden

Phone +46 (0)8 58 60 16 78

www.ecdc.europa.eu


Source: https://www.ecdc.europa.eu/en/news-events/covid-19-vaccination-reduces-risk-long-covid-adults

"Reproduced with permission - European Centre for Disease Prevention and Control (ECDC)"

European Centre for Disease Prevention and Control (ECDC)
www.ecdc.europa.eu


For more HIV and AIDS News visit...

Positively Positive - Living with HIV/AIDS:
HIV/AIDS News


...positive attitudes are not simply 'moods'

Site Map

Contact Bradford McIntyre.

Web Design by Trevor Uksik

Copyright © 2003 - 2025 Bradford McIntyre. All rights reserved.

DESIGNED TO CREATE HIV & AIDS AWARENESS